logo
Hepatitis C - Class Actions Settlement
HomeSearchContact UsFrançaisPrivacy

Claimants:
Essential Information
Claimants:
Additional Information
Claimants:
Loss of Income / Loss of Support / Loss of Services
Periodic Re-Assessment by the Courts
Appeals
Documents
Forms
Contacts and Links
Annual Reports
Administrator


Appeals : Arbitrator Decisions : #108 - October 7, 2003

D E C I S I O N

The Claimant received three (3) blood transfusions in 1987 during an emergency operative treatment.

A few years later, in 1992, his doctors confirmed his HCV infection and therefore, the Claimant submitted a Claim, which was rejected by the Fund's Administrator. The rejection was based on the fact that he failed to prove that his initial HCV infection had occurred after the 1987 transfusion dates.

The Claimant is therefore appealing such a decision.

I had the opportunity to hear the Claimant at a Hearing which took place in Montreal on September 18, 2003, to examine the documentation forwarded to me by the Administrator and the Fund Counsels, and to hear the arguments submitted by both Parties.

The fact that the Claimant received three (3) transfusions in 1987 and that he is HCV infected is not disputed. However, it is determined that the Héma-Québec Traceback had led to the identification of each of the donors who had been tested. Each of the donors proved to be negative. The Claimant questions the results of these tests, in particular concerning one of the donors, whom I will identify for the purposes of this Hearing as number "14", arguing that the label concerning donor 14, attached to the hospital file, had been corrected and that there was confusion regarding the dates.

I listened to the Claimant with a great deal of attention and I am saddened to see the extent of the damages caused to him by the HCV infection. I also listened to the Fund Administrator's Representative, Mr. Antonin Fortier, and as mentioned above, reviewed the documentation that has been forwarded to me, including a letter signed by Héma-Québec's Medical Director (Sainte-Foy), Dr. Marc Germain.

The Claimant sees in his hospital file and in Héma-Québec's documentation matter of confusion and suspicion. I do not agree with his point of view. He received three (3) transfused units on January 16, 1987 and each of the labels clearly identifies the name of the patient (the Claimant), his file number at the Hospital Center, the bag number, the blood type, the transfusion date and time. The only correction made to one of the labels does not seem significant to me, the nurse or the technician having first indicated on label 14 the blood type in the "RH" box. Either the time of the correction or the correction itself that was made by the nurse or the technician, or even by someone else after the transfusion, seems unimportant in our case, as the number on the bag is well identified, and that this number eventually allowed Héma-Québec to do the required tests.

The three (3) donors were effectively traced back, the first one when he made another blood donation in 1992, and the two others in 2002. All three proved to be negative.

Article 3.04(1) of the Transfused HCV Plan stipulates that if the results of a Traceback Procedure show that none of the donors is or was HCV antibody positive, the Administrator must reject the Claim of such HCV Infected Person.

This is clearly our case and the Administrator had to reject the Claim of this Claimant.

Article 3.04(2) allows the Claimant, notwithstanding Article 3.04(1), to prove that he was HCV infected for the first time by a Blood transfusion, and notwithstanding the results of the Traceback Procedure. In this case, the Claimant did not try to submit such a proof, stating only that he had no confidence in label 14 and that he had no confidence in the Héma-Québec's tests. The Claimant did not remove the burden of proof required by Article 3.04(2).

The evidence submitted to me forces me to conclude that the Administrator's decision was well founded and that he had to reject the Claimant's request for compensation.

To come to this conclusion, I chose not to discuss the fact that the plaintiff had a history of several risk factors such as the use of intravenous drugs at least once without medical supervision and the presence of tattoos. These factors can only confirm the fact that the Claimant was not successful in convincing me of the merits of his position.

I confirm the Fund Administrator's Decision and reject the Request for Arbitration.


Montreal, October 7, 2003

(Signature) JACQUES NOLS

Jacques Nols
Arbitrator









 

Disclaimer